All In Biotech

Free tool

FAERS Monitor: Ddavp

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019955 or its brand name (Ddavp, Desmopressin Acetate). Reports on generic versions are filed under their own applications.

Reports

3,313

Serious

2,397

72% of reports

Hospitalization

1,304

Death reported

238

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • hyponatraemia339
  • drug ineffective221
  • headache191
  • nausea181
  • fatigue145
  • off label use143
  • vomiting138
  • dizziness117
  • diarrhoea110
  • pain105
  • asthenia98
  • malaise87
  • pyrexia86
  • dyspnoea84
  • fall83

Reports by year received

View as table
YearReports
200480
200563
200675
200748
2008143
2009147
2010141
2011138
2012167
2013100
2014135
2015133
2016183
2017173
2018166
2019144
2020152
2021172
2022196
2023189
2024255
2025195
2026118

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,846 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hyponatraemiaSignal33938.434.712,283
headache1911.91.788
vomiting1381.91.656
asthenia981.71.425
fall831.61.318
pyrexia861.61.318
dizziness1171.51.219
nausea1811.51.326
malaise871.31.04
fatigue1451.21.04
pain1051.10.91
diarrhoea1101.10.91
drug ineffective2211.10.91
off label use1431.00.90
dyspnoea840.90.80

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.